PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Efavirenz
Presentation Product Chemical substance Chapter Items dispensed
Efavirenz 600mg tablets
0503010D0AAADAD
Efavirenz Efavirenz Infections 1
Efavirenz 100mg capsules
0503010D0AAABAB
Efavirenz Efavirenz Infections No data available
Efavirenz 200mg capsules
0503010D0AAAAAA
Efavirenz Efavirenz Infections No data available
Efavirenz 30mg/ml oral solution sugar free
0503010D0AAAEAE
Efavirenz Efavirenz Infections No data available
Efavirenz 50mg capsules
0503010D0AAACAC
Efavirenz Efavirenz Infections No data available
Sustiva 100mg capsules
0503010D0BBABAB
Sustiva Efavirenz Infections No data available
Sustiva 200mg capsules
0503010D0BBAAAA
Sustiva Efavirenz Infections No data available
Sustiva 30mg/ml oral solution
0503010D0BBAEAE
Sustiva Efavirenz Infections No data available
Sustiva 50mg capsules
0503010D0BBACAC
Sustiva Efavirenz Infections No data available
Sustiva 600mg tablets
0503010D0BBADAD
Sustiva Efavirenz Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.